From Health Disparities to Hotspots to Public Health Strategies: The Impact of the COVID-19 Pandemic in North Carolina

References

1. 1.↵
   1. Centers for Disease Control and Prevention

   . CDC COVID Data Tracker. CDC website. https://covid.cdc.gov/covid-data-tracker/#trends_dailytrendscases. Accessed October 16, 2020.
2. 2.↵
   1. North Carolina Department of Health and Human Services

   . NCDHHS’ COVID-19 Response. NC DHHS website. https://covid19.ncdhhs.gov. Accessed October 30, 2020.
3. 3.↵
   1. Stokes EK,
   2. Zambrano LD,
   3. Anderson KN, et al.

   Coronavirus disease 2019 case surveillance – United States, January 22–May 30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(24);759-765. doi: 10.15585/mmwr.mm6924e2

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Boehmer TK,
   2. DeVies J,
   3. Caruso E. et al.

   Changing age distribution of the COVID-19 pandemic – United States, May–August 2020. MMWR Morb Mortal Wkly Rep. 2020;69(39);1404-1409. doi: 10.15585/mmwr.mm6939e1

   OpenUrlCrossRef
5. 5.↵
   1. Centers for Disease Control and Prevention

   . COVID-19 Hospitalization and Death by Race/Ethnicity. CDC website. https://www.cdc.gov/coronavirus/2019-ncov/covid-data/investigations-discovery/hospitalization-death-by-race-ethnicity.html#footnote02. Updated August 18, 2020. Accessed October 16, 2020.
6. 6.↵
   1. Moore JT,
   2. Ricaldi JN,
   3. Rose CE, et al.

   Disparities in incidence of COVID-19 among underrepresented racial/ethnic groups in counties identified as hotspots during June 5-18, 2020 – 22 states, February– June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(33):1122-1126. doi: 10.15585/mmwr.mm6933e1

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Corbie-Smith G,
   2. Wolfe MK,
   3. Hoover SM,
   4. Dave G,
   5. Richmond A.

   Centering equity and community in the recovery of the COVID-19 pandemic. N C Med J. 2021;82(1):62-67 (in this issue).

   OpenUrlAbstract/FREE Full Text
8. 8.↵
   1. Hendrix GJ.

   Addressing North Carolina Hispanics and Latinos affected by COVID-19: A grassroots approach. N C Med J. 2021;82(1):64-65 (in this issue).

   OpenUrlFREE Full Text
9. 9.↵
   1. Lash RR,
   2. Donovan CV,
   3. Fleischauer AT.

   COVID-19 contact tracing in two counties — North Carolina, June–July 2020. MMWR Morb Mortal Wkly Rep. 2020;69(38);1360-1363. doi: 10.15585/mmwr.mm6938e3

   OpenUrlCrossRef
10. 10.↵
    1. Marvel SW,
    2. House JS,
    3. Wheeler M, et al.

    The COVID-19 Pandemic Vulnerability Index (PVI) Dashboard: Monitoring county-level vulnerability using visualization, statistical modeling, and machine learning. Preprint. medRxiv. 2020. doi: https://doi.org/10.1101/2020.08.10.20169649
11. 11.↵
    1. National Institute of Environmental Health Sciences

    . COVID-19 Pandemic Vulnerability Index. COVID-19 PVI website. https://covid-19pvi.niehs.nih.gov. Accessed October 16, 2020.
12. 12.↵
    1. Pettigrew E.

    COVID-19: A mirror to our flaws. N C Med J. 2021;82(1):43-45 (in this issue).

    OpenUrlAbstract/FREE Full Text
13. 13.↵
    1. Gerald L.

    Invest in rural North Carolina to ensure a thriving state, pandemic or not. N C Med J. 2021;82(1):46-49 (in this issue).

    OpenUrlAbstract/FREE Full Text
14. 14.↵
    1. Fierabracci A,
    2. Arena A,
    3. Rossi P.

    COVID-19: a review on diagnosis, treatment, and prophylaxis. Int J Mol Sci. 2020;21(14):5145. doi: 10.3390/ijms21145145

    OpenUrlCrossRef
15. 15.↵
    North Carolina Has First Reported SARS-CoV-2 Positive Case in Dog [press release]. Raleigh, NC: NC DHHS; August 11, 2020. https://www.ncdhhs.gov/news/press-releases/north-carolina-has-first-reported-sars-cov-2-positive-case-dog. Accessed October 16, 2020.
16. 16.↵
    1. Centers for Disease Control and Prevention

    . Contact Tracing. CDC website. https://www.cdc.gov/coronavirus/2019-ncov/daily-life-coping/contact-tracing.html. Accessed October 15, 2020.
17. 17.↵
    1. He X,
    2. Lau EHY,
    3. Wu P, et al.

    Author correction: Temporal dynamics in viral shedding and transmissibility of COVID -19. Nat Med. 2020;69(9):1491-1493. doi: 10.1038/s41591-020-1016-z

    OpenUrlCrossRef
18. 18.↵
    1. Centers for Disease Control and Prevention

    . Scientific Brief: SARS-CoV-2 and Potential Airborne Transmission. CDC website. https://www.cdc.gov/coronavirus/2019-ncov/more/scientific-brief-sars-cov-2.html. Updated October 5, 2020. Accessed October 15, 2020.
19. 19.↵
    1. van Doremalen N,
    2. Bushmaker T,
    3. Morris DH, et al.

    Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. New Eng J Med. 2020;382(16):1564-1567. doi: 10.1056/NEJMc2004973

    OpenUrlCrossRefPubMed
20. 20.↵
    1. Centers for Disease Control and Prevention

    . Hand Hygiene Recommendations. CDC website. https://www.cdc.gov/coronavirus/2019-ncov/hcp/hand-hygiene.html. Updated May 17, 2020. Accessed October 30, 2020.
21. 21.↵
    1. Madewell ZJ,
    2. Yang Y,
    3. Longini IM, et al.

    Household transmission of SARS-CoV-2: a systematic review and meta-analysis of secondary attack rate. Preprint. medRxiv. 2020. doi: 10.1101/2020.07.29.20164590.

    OpenUrlCrossRef
22. 22.↵
    1. Centers for Disease Control and Prevention

    . Duration of Isolation and Precautions for Adults with COVID-19. CDC website. https://www.cdc.gov/coronavirus/2019-ncov/hcp/duration-isolation.html. Updated October 19, 2020. Accessed October 16, 2020.
23. 23.↵
    1. Sickbert-Bennett E,
    2. DiBiase L.

    COVID-19 surveillance: Not everything that counts can be counted and not everything that can be counted counts. N C Med J. 2021;82(1):71-74 (in this issue).

    OpenUrlAbstract/FREE Full Text
24. 24.↵
    1. U.S. Food and Drug Administration

    . Coronavirus Testing Basics. Silver Spring, MD: FDA; 2020. https://www.fda.gov/media/140161/download. Published July 2020. Accessed October 16, 2020.
25. 25.↵
    1. Centers for Disease Control and Prevention

    . Overview of Testing for SARS-CoV-2 (COVID-19). CDC website. https://www.cdc.gov/coronavirus/2019-ncov/hcp/testing-overview.html. Updated October 21, 2020. Accessed October 16, 2020.
26. 26.↵
    1. Centers for Disease Control and Prevention

    . Interim Guidelines for COVID-19 Antibody Testing. CDC website. https://www.cdc.gov/coronavirus/2019-ncov/lab/resources/antibody-tests-guidelines.html. Updated August 1, 2020. Accessed October 16, 2020.
27. 27.↵
    1. To KK-W,
    2. Hung IF-N,
    3. Chan K-H, et al.

    Serum antibody profile of a patients with COVID-19 reinfection. Clin Infect Dis. 2020. doi: 10.1093/cid/ciaa1368

    OpenUrlCrossRef
28. 28.↵
    1. Barzin A,
    2. Schmitz JL,
    3. Rosin S, et al.

    SARS-CoV-2 seroprevalence among a southern U.S. population indicates limited asymptomatic spread under physical distancing measures. mBio. 2020;11(5):e02426-20. doi: 10.1128/mBio.02426-20

    OpenUrlCrossRef
29. 29.↵
    1. Shuchi A,
    2. Montez-Rath M,
    3. Han J, et al.

    Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study. Lancet. 2020;396(10259):1335-44. doi: 10.1016/S0140-6736(20)32009-2

    OpenUrlCrossRefPubMed
30. 30.↵
    1. National Institutes of Health

    . COVID-19 Treatment Guidelines: What’s New in the Guidelines. NIH website. https://www.covid19treatmentguidelines.nih.gov/whats-new. Updated October 9, 2020. Accessed October 16, 2020.
31. 31.↵
    1. Morris SB,
    2. Schwartz NG,
    3. Patel P, et al.

    Case series of multisystem inflammatory syndrome in adults associated with SARS-CoV-2 Infection - United Kingdom and United States, March-August 2020. MMWR Morb Mortal Wkly Rep. 2020;69(40):1450-1456. doi: 10.15585/mmwr.mm6940e1

    OpenUrlCrossRef
32. 32.↵
    1. Rolfe RJ,
    2. Smith CM,
    3. Wolfe CR.

    The emerging chronic sequelae of COVID-19 and implications for North Carolina. N C Med J. 2021;82(1):75-78 (in this issue).

    OpenUrlAbstract/FREE Full Text
33. 33.↵
    1. U.S. Food and Drug Administration

    . Letter from RADM Denise M. Hinton to Ashley Rhoades, Gilead Sciences, Inc. Silver Spring, MD: FDA; 2020. https://www.fda.gov/media/137564/download. Released October 22, 2020. Accessed October 29, 2020.
34. 34.↵
    1. Oster AM,
    2. Kang GJ,
    3. Che AE, et al.

    Trends in number and distribution of COVID-19 hotspot counties – United States, March 8–July 15, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(33):1127-1132. doi: 10.15585/mmwr.mm6933e2

    OpenUrlCrossRef
35. 35.↵
    1. Boucher N.

    No Hugs Allowed: Isolation and inequity in North Carolina long-term services and supports during COVID-19. N C Med J. 2021;82(1):57-61 (in this issue).

    OpenUrlAbstract/FREE Full Text
36. 36.↵
    1. Rivest M.

    COVID-19 devastates North Carolina’s child care system and threatens health and safety of children, families, and early educators. N C Med J. 2021;82(1):52-53 (in this issue).

    OpenUrlFREE Full Text
37. 37.↵
    1. Boutzoukas AE.
    2. Akinboyo IC,
    3. Wong CA,
    4. Benjamin DK,
    5. Zimmerman KO.

    Impact of COVID-19-related school closures on the drivers of child health. N C Med J. 2021;82(1):50-56 (in this issue).

    OpenUrlAbstract/FREE Full Text
38. 38.↵
    1. Wilson E,
    2. Donovan CV,
    3. Campbell M, et al.

    Multiple COVID-19 clusters on a university campus – North Carolina, August 2020. MMWR Morb Mortal Wkly Rep. 2020;69(39):1416-1418. doi: 10.15585/mmwr.mm6939e3

    OpenUrlCrossRef
39. 39.↵
    1. Pease RC,
    2. Keen SK,
    3. Coleman GC,
    4. Pettigrew EM,
    5. Porterfield DS.

    Orange County, NC interdisciplinary “strike team” supports high-risk congregate living facilities in COVID-19 response. N C Med J. 2021;82(1):58-59 (in this issue).

    OpenUrlFREE Full Text
40. 40.↵
    1. Fiscus L,
    2. Towns R,
    3. Wood S, et al.

    Deploying mobile COVID-19 testing programs in North Carolina as an approach to improve health equity. N C Med J. 2021;82(1):80-82 (in this issue).

    OpenUrlFREE Full Text
41. 41.↵
    1. Sturgill A.

    Health care providers can help combat harmful misinformation about the pandemic. N C Med J. 2021;82(1):68-70 (in this issue).

    OpenUrlAbstract/FREE Full Text